fda semaglutide compounding warning november 2025 Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots FDA warns consumers not to

When prescribed, medications are prepared by licensed 503A compounding pharmacies for eligible patients

Premium positioning: as volume decreases, perceived value has to rise

Incretin therapies that target gastric inhibitory polypeptide (GIP) or glucagon-like peptide-1 (GLP-1) offer new ways to manage blood glucose levels, body weight, and lipid metabolism

You will move towards achieving your goals, and your hard work will pay off

Enhances Overall Wellness By addressing metabolic challenges and reducing inflammatory responses, GLP-1 medications can support better energy levels and overall well-being, making it easier for patients to engage in physical activity and maintain a balanced lifestyle